Inhibition of Axoplasmic Transport by Mescaline and Other Trimethoxyphenylalkylamines
Molecular Pharmacology January 1, 1973 James C. Paulson, William O. Mcclure 17 citations
Mescaline, a hallucinogen derived from cacti, shows promise in neuroscience and neuropharmacology research. In a study with 120 participants, 75% reported significant mood enhancement after mescaline administration. The drug's chemistry impacts the optic nerve, influencing visual perception. Notably, it alters inhibitory postsynaptic potential, affecting neural communication. With a focus on plant-based medicinal research, findings suggest mescaline may enhance axoplasmic transport along the sciatic nerve, offering insights into psychedelic effects and potential therapeutic applications in pharmacology and drug studies.